Talis Biomedical Corp Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Talis Biomedical Corp quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
  • Talis Biomedical Corp Current Ratio for the quarter ending June 30, 2024 was 866 %, a 23.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 866 -261 -23.2% Jun 30, 2024
Q1 2024 947 -220 -18.9% Mar 31, 2024
Q4 2023 1.02K -215 -17.4% Dec 31, 2023
Q3 2023 1.06K -216 -17% Sep 30, 2023
Q2 2023 1.13K +10.7 +0.96% Jun 30, 2023
Q1 2023 1.17K +394 +51.1% Mar 31, 2023
Q4 2022 1.24K +496 +67% Dec 31, 2022
Q3 2022 1.28K +550 +75.7% Sep 30, 2022
Q2 2022 1.12K Jun 30, 2022
Q1 2022 772 Mar 31, 2022
Q4 2021 741 Dec 31, 2021
Q3 2021 726 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.